CRPC w/ Bone Metastases

Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers. January 19, 2021

Randomized phase II trial of sipuleucel-T with or without radium-223 in men with bone-metastatic castration-resistant prostate cancer. January 18, 2021

The Effect of Radium-223 Therapy in Agent Orange-Related Prostate Carcinoma. January 13, 2021

Evaluation of safety and dosimetry of 177Lu DOTA-ZOL for therapy of bone metastases. January 11, 2021

External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy. January 4, 2021

Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine. December 29, 2020

Bone Infarction Mimicking a Bone Metastasis on 18F-Prostate-Specific Membrane Antigen PET/CT. December 22, 2020

Management of cancer pain with analgetic adjuvant and weak opioid in prostate cancer bone metastases: A case series. December 14, 2020

Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow. December 11, 2020

Mechanobiological evaluation of prostate cancer metastasis to bone using an in vitro prostate cancer testbed. December 10, 2020

Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis. December 7, 2020

The Role of Theranostics in Prostate Cancer. December 2, 2020

Radium-223 therapy for metastatic castration-resistant prostate cancer: survival benefit when used earlier in the treatment pathway. December 2, 2020

Radiopharmaceuticals for Bone Metastases. December 1, 2020

Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells. November 30, 2020

Review of Palliative Radium 223 (223Ra) in metastatic castration resistant prostate cancer (mCRPC): Experience at West Virginia University (WVU) Cancer Center. November 24, 2020

Bone-targeted calcium phosphate-polymer hybrid nanoparticle co-deliver zoledronate and docetaxel to treat bone metastasis of prostate cancer. November 18, 2020

Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis. November 17, 2020

Aggressive Bone Metastatic Prostate Cancer With Periosteal Reaction in 18F-Choline PET/CT. November 16, 2020

Pharmacologic Management of Metastatic Bone Disease. November 13, 2020

Page 1 of 13